Phio Pharmaceuticals Reports Third Quarter 2020 Financial Results and Provides Business UpdatePRNewsWire • 11/10/20
Phio Announces Positive In Vivo Data On Combination PD-1 And TIGIT Checkpoint Blockade With INTASYL In A Single Therapeutic For Cancer TreatmentPRNewsWire • 11/09/20
Phio Pharmaceuticals Announces Three Poster Presentations at the 2020 Society for Immunotherapy of Cancer (SITC) Annual MeetingPRNewsWire • 10/26/20
Phio Pharmaceuticals to Present at the H.C. Wainwright 22nd Annual Global Investment ConferencePRNewsWire • 09/09/20
Phio Pharmaceuticals Reports Second Quarter 2020 Financial Results and Provides Business UpdatePRNewsWire • 08/12/20
Phio Presents Data on INTASYL as an Alternative to Genetic Modification to Improve Cell-based Immunotherapy at ASGCT 2020PRNewsWire • 05/14/20